Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report

JTO Clin Res Rep. 2021 Oct 11;2(11):100236. doi: 10.1016/j.jtocrr.2021.100236. eCollection 2021 Nov.


Malignant mesothelioma with EWSR1-ATF1 fusion is a rare malignancy described in young adults without asbestos exposure. To the best of our knowledge, outcomes to local and systemic therapies for this subtype of malignant mesothelioma have not been described. This case report describes the clinical course of a 19-year-old man diagnosed with malignant peritoneal mesothelioma with EWSR1-ATF1 fusion localized to the abdomen. His disease followed an aggressive course and resulted in limited survival (18 mo). There was treatment resistance to several lines of conventional local and systemic treatments for peritoneal mesothelioma and biologically targeted MET inhibition with crizotinib. More research is required in this rare subtype of peritoneal mesothelioma.

Keywords: ATF1; Case report; EWSR1; Peritoneal mesothelioma.

Publication types

  • Case Reports